Circulating tumor cells (CTCs) have become a blistering topic of discussion for oncologists
because of their tremendous potential in the diagnosis and treatment of cancer. Over the …

Circulating tumor cells (CTCs) are rare malignant cells found in the peripheral blood that
originate from the primary tumor or metastatic sites. New techniques have been developed …

Circulating tumor cells (CTC) can be detected in the peripheral blood of patients with a
variety of solid cancers. Because of their very low frequency, these tumor cells are not easily …

Abstract Background Circulating tumor cells (CTCs) have long been considered a reflection
of tumor aggressiveness. Hematogenous spreading of CTCs from a primary tumor is a …

Circulating tumor cells (CTCs) represent a surrogate biomarker of hematogenous
metastases. In recent years, their detection has gained increasing interest. There is ample …

The presence of circulating tumor cells (CTCs) in peripheral blood can serve as a “liquid
biopsy” approach and has thus emerged lately as one of the hottest fields in cancer …

Circulating tumor cells (CTCs) can be separated and characterized from normal
hematopoietic cellular constituents by a variety of methods. Different strategies have …

Circulating tumour cells (CTCs) can be detected in the blood of many patients with different
types of early or advanced cancer using antibody-based assays or molecular methods. In …

Circulating tumor cells (CTCs) could be considered a sign of tumor aggressiveness, but
highly sensitive and specific methods of CTC detection are necessary owing to the rarity and …

Circulating tumor cells (CTCs) can be detected in the blood of different types of early or
advanced cancer using immunology-based assays or nucleic acid methods. The detection …